Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 477.32
   
  • Change Today:
    $-14.15
  • 52 Week High: $513.76
  • 52 Week Low: $374.46
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 1,721,412
  • Market Cap: $112,643m
  • RiskGrade: 164

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500Nasdaq 100Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 477.32
Change Today $ -14.15
% Change -2.88 %
52 Week High $513.76
52 Week Low $374.46
Volume 1,721,412
Shares Issued 235.99m
Market Cap $112,643m
RiskGrade 164

What The Brokers Say

Strong Buy 9
Buy 11
Neutral 8
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page